Increasing Trintellix to 20 mg is Strongly Recommended Before Adding Lamotrigine
You should increase your Trintellix dose to 20 mg/day, as this dose demonstrates significantly greater efficacy than 10 mg for major depressive disorder, with faster onset of response and better sustained improvement. 1
Why 20 mg is Superior to 10 mg
The evidence clearly shows a dose-response relationship for vortioxetine (Trintellix):
- 20 mg separates from placebo by week 2, while 10 mg doesn't show significant separation until week 4 2
- At 8 weeks, 20 mg produces significantly greater MADRS score reduction compared to 10 mg (difference of -1.03 points, p<0.05) 2
- Response rates are higher: 39.2% vs 33.8% for 20 mg vs 10 mg 3
- Sustained response from week 4: 26.0% with 20 mg vs 19.1% with 10 mg (p<0.01) 4
- In flexible-dose studies, 64.3% of patients ultimately required 20 mg as their final dose, with nearly half needing this increase after just 1 week 2
Critically, the tolerability profile is similar between 10 mg and 20 mg doses - adverse event rates don't increase meaningfully at the higher dose 2, 4. The FDA label explicitly states the dose "should then be increased to 20 mg/day, as tolerated" 1.
Timing and Approach for Dose Increase
- Increase to 20 mg after 1-2 weeks at 10 mg if tolerated
- In clinical trials, rapid escalation to 20 mg by day 8 was well-tolerated and effective 5
- Allow 6-8 weeks total treatment duration at the therapeutic dose before considering the trial inadequate 6
- Most common side effect is nausea, but rapid dose escalation doesn't intensify this 5
When to Consider Adding Lamotrigine
Only consider lamotrigine augmentation after an adequate trial of vortioxetine 20 mg for 6-8 weeks shows insufficient response (defined as <30% symptom reduction or average pain/depression remaining ≥4/10) 6.
Important Caveats About Lamotrigine:
The evidence for lamotrigine in unipolar depression is limited:
- Lamotrigine is primarily studied for bipolar depression, not unipolar major depressive disorder 7
- When added to lithium in bipolar depression, lamotrigine showed benefit, but adding paroxetine to lithium+lamotrigine provided no additional benefit 7
- There is insufficient evidence to support lamotrigine as a standard augmentation strategy in unipolar depression following SSRI/SNRI failure
Better-Supported Next Steps if 20 mg Fails:
According to depression treatment guidelines 6:
- Switch to a different antidepressant class (evidence shows switching can be effective)
- Add psychotherapy (combination therapy shows superior outcomes)
- Consider other augmentation strategies with stronger evidence bases
- Referral to psychiatry for treatment-resistant depression evaluation
Common Pitfall to Avoid
Don't prematurely add augmentation agents while still on a subtherapeutic dose. You're currently on 10 mg, which is essentially a starting dose. The evidence strongly indicates that 20 mg is the therapeutic target dose for most patients 8, 2, 4. Adding lamotrigine now would be premature and not evidence-based for unipolar depression.
Your immediate next step should be increasing to vortioxetine 20 mg/day and reassessing after 6-8 weeks at that dose.